CID 3048770
Sarmentoside a monoacetate
Structural Information
- Molecular Formula
- C31H44O12
- SMILES
- C[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)C5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)OC(=O)C)C=O)O)O)O
- InChI
- InChI=1S/C31H44O12/c1-15-24(36)25(37)26(38)27(41-15)42-18-4-7-29(14-32)23-20(5-8-30(29,39)11-18)31(43-16(2)33)9-6-19(17-10-22(35)40-13-17)28(31,3)12-21(23)34/h10,14-15,18-21,23-27,34,36-39H,4-9,11-13H2,1-3H3/t15-,18-,19+,20+,21+,23+,24+,25+,26+,27-,28+,29-,30-,31?/m0/s1
- InChIKey
- HYKKZGHORGQJEF-YSHVTHLUSA-N
- Compound name
- [(3S,5S,8R,9S,10S,11R,13R,17R)-10-formyl-5,11-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2R,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-14-yl] acetate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 609.29054 | 239.1 |
[M+Na]+ | 631.27248 | 241.3 |
[M-H]- | 607.27598 | 236.3 |
[M+NH4]+ | 626.31708 | 239.7 |
[M+K]+ | 647.24642 | 241.1 |
[M+H-H2O]+ | 591.28052 | 231.0 |
[M+HCOO]- | 653.28146 | 241.6 |
[M+CH3COO]- | 667.29711 | 255.2 |
[M+Na-2H]- | 629.25793 | 253.9 |
[M]+ | 608.28271 | 239.8 |
[M]- | 608.28381 | 239.8 |
Literature stripe
No literature data available for this compound.
Patent stripe
No patent data available for this compound.